Identifying value in healthcare transformation initiatives: an evaluation of an approach to benefits realisation.

Evaluation methodology Healthcare quality improvement PDSA Quality improvement methodologies Quality measurement

Journal

BMJ open quality
ISSN: 2399-6641
Titre abrégé: BMJ Open Qual
Pays: England
ID NLM: 101710381

Informations de publication

Date de publication:
10 2023
Historique:
received: 16 03 2023
accepted: 25 09 2023
medline: 23 10 2023
pubmed: 20 10 2023
entrez: 19 10 2023
Statut: ppublish

Résumé

Benefits realisation management (BRM) aims to facilitate the process of identifying, measuring and tracking desired benefits derived from a project. Improvement methodology frameworks often describe BRM as integral to identifying and measuring value derived from transformation initiatives within the National Health Service and beyond. Despite this, reporting of benefits realisation plans and methodological approaches to identifying and measuring benefits remains surprisingly scarce.This project aimed to pilot and evaluate the application of a purpose-designed benefits mapping template with seven newly funded transformation projects across three hospitals in the UK. The scope of the template was to identify key project benefits and metrics associated with the project initiatives. Plan-do-study-act (PDSA) cycles were used to capture the approach and utilisation of the template by project teams. These methods also enabled critical review of the template as an enabler to identifying relevant benefits and project metrics.Stakeholder engagement with the templates was variable. This was attributed to clinical pressures induced by the second wave of COVID-19 in the UK. Despite this, teams were able to produce completed templates outlining a number of wide-ranging benefits. Themes of benefits drawn from the maps include patient experience, patient outcomes, staff experience, access to care and efficiency. Qualitative feedback from teams included the reported value of a structured template to help recognise all the potential benefits associated with each project initiative. The PDSA cycles highlighted the template as an early step in BRM. Further components to this process are recommended to include consensus of the key metrics to be measured, a tool that summarises the reporting details of those metrics, and an effective means to collate reported metrics overtime.

Identifiants

pubmed: 37857520
pii: bmjoq-2023-002349
doi: 10.1136/bmjoq-2023-002349
pmc: PMC10603506
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

BMJ Open. 2021 Jun 11;11(6):e048815
pubmed: 34117048
BMJ. 2013 Jan 28;346:f167
pubmed: 23358487
Cureus. 2017 Mar 2;9(3):e1067
pubmed: 28409068
Educ Prim Care. 2015 Jul;26(4):279-81
pubmed: 26253069
Int J Qual Health Care. 2018 Aug 01;30(7):508-513
pubmed: 29635294

Auteurs

Venessa Vas (V)

KHP Cardiovascular & Respiratory Partnership, Guy's and St Thomas' NHS Foundation Trust, London, UK venessa.vas@gstt.nhs.uk.

Loretta Gyambibi (L)

KHP Cardiovascular & Respiratory Partnership, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Linda Eftychiou (L)

KHP Cardiovascular & Respiratory Partnership, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Hassan Al-Omari (H)

KHP Cardiovascular & Respiratory Partnership, Guy's and St Thomas' NHS Foundation Trust, London, UK.

James Glass (J)

KHP Cardiovascular & Respiratory Partnership, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Mark Smith (M)

KHP Cardiovascular & Respiratory Partnership, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Dionne Matthew (D)

KHP Cardiovascular & Respiratory Partnership, Guy's and St Thomas' NHS Foundation Trust, London, UK.
LOGEX, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH